Literature DB >> 19476564

Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates.

Nattawan Promadej-Lanier1, James M Smith, Priya Srinivasan, Clare F McCoy, Sal Butera, A David Woolfson, R Karl Malcolm, Ron A Otten.   

Abstract

BACKGROUND: There is considerable interest in developing coitally independent, sustained release formulations for long-term administration of HIV microbicides. Vaginal ring devices are at the forefront of this formulation strategy.
METHODS: Non-medicated silicone elastomer vaginal rings were prepared having a range of appropriate dimensions for testing vaginal fit in pig-tailed and Chinese rhesus macaques. Cervicovaginal proinflammatory markers were evaluated. Compression testing was performed to compare the relative flexibility of various macaque and commercial human rings.
RESULTS: All rings remained in place during the study period and no tissue irritation or significant induction of cervicovaginal proinflammatory markers or signs of physical discomfort were observed during the 8-week study period.
CONCLUSIONS: Qualitative evaluation suggests that the 25 x 5-mm ring provided optimal fit in both macaque species. Based on the results presented here, low-consistency silicone elastomers do not cause irritation in macaques and are proposed as suitable materials for the manufacture of microbicide-loaded vaginal rings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19476564     DOI: 10.1111/j.1600-0684.2009.00354.x

Source DB:  PubMed          Journal:  J Med Primatol        ISSN: 0047-2565            Impact factor:   0.667


  21 in total

1.  A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates.

Authors:  Jonathan T Su; Ryan S Teller; Priya Srinivasan; Jining Zhang; Amy Martin; Samuel Sung; James M Smith; Patrick F Kiser
Journal:  Pharm Res       Date:  2017-08-02       Impact factor: 4.200

2.  Lack of in vitro-in vivo correlation for a UC781-releasing vaginal ring in macaques.

Authors:  Christopher McConville; James M Smith; Clare F McCoy; Priya Srinivasan; James Mitchell; Angela Holder; Ron A Otten; Salvatore Butera; Gustavo F Doncel; David R Friend; R Karl Malcolm
Journal:  Drug Deliv Transl Res       Date:  2015-02       Impact factor: 4.617

3.  Partial protection against multiple RT-SHIV162P3 vaginal challenge of rhesus macaques by a silicone elastomer vaginal ring releasing the NNRTI MC1220.

Authors:  Susan M Fetherston; Leslie Geer; Ronald S Veazey; Laurie Goldman; Diarmaid J Murphy; Thomas J Ketas; Per Johan Klasse; Sylvain Blois; Paolo La Colla; John P Moore; R Karl Malcolm
Journal:  J Antimicrob Chemother       Date:  2012-10-28       Impact factor: 5.790

4.  Characterization of the Genital Microenvironment of Female Rhesus Macaques Prior to and After SIV Infection.

Authors:  Whitney A Nichols; Leslie Birke; Jason Dufour; Nisha Loganantharaj; Gregory J Bagby; Steve Nelson; Patricia E Molina; Angela M Amedee
Journal:  Am J Reprod Immunol       Date:  2015-08-20       Impact factor: 3.886

5.  Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.

Authors:  John A Moss; Amanda M Malone; Thomas J Smith; Sean Kennedy; Etana Kopin; Cali Nguyen; Josh Gilman; Irina Butkyavichene; Kathleen L Vincent; Massoud Motamedi; David R Friend; Meredith R Clark; Marc M Baum
Journal:  Antimicrob Agents Chemother       Date:  2011-11-28       Impact factor: 5.191

6.  Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings.

Authors:  Todd J Johnson; Priya Srinivasan; Theodore H Albright; Karen Watson-Buckheit; Lorna Rabe; Amy Martin; Chou-Pong Pau; R Michael Hendry; Ron Otten; Janet McNicholl; Robert Buckheit; James Smith; Patrick F Kiser
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

7.  Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.

Authors:  James M Smith; Rachna Rastogi; Ryan S Teller; Priya Srinivasan; Pedro M M Mesquita; Umadevi Nagaraja; Janet M McNicholl; R Michael Hendry; Chuong T Dinh; Amy Martin; Betsy C Herold; Patrick F Kiser
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

8.  Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model.

Authors:  John A Moss; Priya Srinivasan; Thomas J Smith; Irina Butkyavichene; Gilbert Lopez; Amanda A Brooks; Amy Martin; Chuong T Dinh; James M Smith; Marc M Baum
Journal:  Antimicrob Agents Chemother       Date:  2014-06-16       Impact factor: 5.191

9.  Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques.

Authors:  John A Moss; Amanda M Malone; Thomas J Smith; Irina Butkyavichene; Cassandra Cortez; Joshua Gilman; Sean Kennedy; Etana Kopin; Cali Nguyen; Preetha Sinha; R Michael Hendry; Patricia Guenthner; Angela Holder; Amy Martin; Janet McNicholl; James Mitchell; Chou-Pong Pau; Priya Srinivasan; James M Smith; Marc M Baum
Journal:  Antimicrob Agents Chemother       Date:  2012-09-10       Impact factor: 5.191

10.  A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.

Authors:  Todd J Johnson; Meredith R Clark; Theodore H Albright; Joel S Nebeker; Anthony L Tuitupou; Justin T Clark; Judit Fabian; R Tyler McCabe; Neelima Chandra; Gustavo F Doncel; David R Friend; Patrick F Kiser
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.